Health - Google News: Backlash Over New Gilead AIDS Drug Begins - Forbes

Health - Google News Google News

Backlash Over New Gilead AIDS Drug Begins - Forbes Aug 31st 2012, 15:45 Backlash Over New Gilead AIDS Drug Begins Forbes And so, the battle begins. As soon as Gilead Sciences announced that the price for its newly approved Stribild HIV medication – a once-daily combination pill – would be $28500 annually, some AIDS activists threatened to take action to find a way to ... High Price of HIV Drug Prompts SF Ballot MeasureSirius XM OutQ News FDA Approves Combination HIV DrugThe Disease Daily Targeting Gilead, AIDS Healthcare Foundation seeks SF referendum on HIV drug ...San Francisco Business Times (blog) MedCity News -WSAV-TV -Nature.com all 13 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: